You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The role of pharmacokinetics in bioequivalence of studies of inhalation drugs
- In: MINI-SYMPOSIUM: CHALLENGES IN BIOEQUIVALENCE FOR INHALED PRODUCTS on Monday, 14 April 2014, 09:00-10:00
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: HOCHHAUS, Guenther (University of Florida, Pharmaceutics, Gainesville, United States of America)
- Abstract:
I. Background: Demonstrating the bioequivalence of inhaltion drugs is a challenge. Currently in vitro, pharmacokinetic and pharmacodynamic clinical studies are employed with european (EMA) and north-american (FDA) differing significantly 2. Aims: Aim of this presentation is it to discuss advantages and disadvantages of above methods. 3. Methods:..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026